Page last updated: 2024-08-22

buthionine sulfoximine and nedocromil

buthionine sulfoximine has been researched along with nedocromil in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, JK; Chinta, SJ; Rajagopalan, S	1

Other Studies

1 other study(ies) available for buthionine sulfoximine and nedocromil

Article	Year
Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's disease. CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:1 Topics: Age Factors; Analysis of Variance; Animals; Buthionine Sulfoximine; Cell Line, Transformed; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Hydroxybenzoates; Mass Spectrometry; Mice; Mice, Transgenic; Mitochondria; Oxygen Consumption; Parkinson Disease; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Rats; Substantia Nigra	2014

Article

Year

Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's disease.

CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:1

Topics: Age Factors; Analysis of Variance; Animals; Buthionine Sulfoximine; Cell Line, Transformed; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Hydroxybenzoates; Mass Spectrometry; Mice; Mice, Transgenic; Mitochondria; Oxygen Consumption; Parkinson Disease; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Rats; Substantia Nigra

2014